JAZZ

Jazz Pharmaceuticals plc Healthcare - Pharmaceuticals Investor Relations →

NO
25.5% ABOVE
↑ Moving away Was 24.7% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $131.91
14-Week RSI 65

Jazz Pharmaceuticals plc (JAZZ) closed at $165.50 as of 2026-02-02, trading 25.5% above its 200-week moving average of $131.91. The stock moved further from the line this week, up from 24.7% last week. The 14-week RSI sits at 65, indicating neutral momentum.

Over the past 927 weeks of data, JAZZ has crossed below its 200-week moving average 18 times. On average, these episodes lasted 21 weeks. Historically, investors who bought JAZZ at the start of these episodes saw an average one-year return of +16.0%.

With a market cap of $10.1 billion, JAZZ is a large-cap stock. The company generates a free cash flow yield of 15.2%, which is notably high. Return on equity stands at -9.1%. The stock trades at 2.5x book value.

Over the past 17.8 years, a hypothetical investment of $100 in JAZZ would have grown to $2163, compared to $684 for the S&P 500. That represents an annualized return of 18.8% vs 11.4% for the index — confirming JAZZ as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

In the past 12 months, corporate insiders have made 1 open-market purchase totaling $9,993,082.

Free cash flow has been growing at a 22.5% compound annual rate, with 4 consecutive years of positive cash generation.

Growth of $100: JAZZ vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After JAZZ Crosses Below the Line?

Across 18 historical episodes, buying JAZZ when it crossed below its 200-week moving average produced an average return of +19.2% after 12 months (median +8.0%), compared to +14.7% for the S&P 500 over the same periods. 53% of those episodes were profitable after one year. After 24 months, the average return was +52.2% vs +28.8% for the index.

Each line shows $100 invested at the moment JAZZ crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Insider Buying Activity

1 conviction buy in the past 12 months (purchases over $500K with meaningful position increases).

DateInsiderTitleValueSharesPosition +%
2025-05-12MULLIGAN SEAMUS C.Director$9,993,082101,621N/A

Historical Touches

JAZZ has crossed below its 200-week MA 18 times with an average 1-year return of +16.0% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
May 2008Aug 20096993.1%-90.1%+1785.0%
Oct 2009Dec 2009718.9%+50.7%+2167.1%
May 2010Jun 201025.4%+278.9%+2080.5%
Feb 2016Feb 201611.9%+15.1%+45.5%
Aug 2016Mar 20173023.3%+13.6%+28.8%
Aug 2017Aug 201732.2%+23.4%+16.0%
Sep 2017Jan 20181510.0%+15.0%+13.2%
Jan 2018Mar 201855.2%-10.8%+15.1%
Mar 2018Mar 201810.0%-7.7%+11.8%
Apr 2018May 201810.6%-10.1%+12.4%
Nov 2018Nov 201824.2%-10.6%+13.7%
Dec 2018Nov 20195021.8%+5.9%+17.2%
Feb 2020Sep 20203132.0%+18.9%+17.5%
Aug 2021Feb 20222916.5%+10.5%+16.4%
Sep 2022Oct 202259.7%+3.2%+29.6%
Mar 2023Mar 202336.4%-12.3%+23.5%
Apr 2023Feb 20259629.0%-22.1%+17.8%
Mar 2025Sep 20252726.5%N/A+34.6%
Average21+16.0%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02